Hikma Pharmaceuticals PLC - 関連ニュース

NewsProactive Investors

Panmure Liberum raises Hikma target price to 1,900p

Panmure Liberum has raised its target price for Hikma Pharmaceuticals PLC (LSE:HIK, OTC:HKMPF) from 1,600p to 1,900p, saying the drugmaker's strong first-half results support further upside in its sha

12 days ago

NewsProactive Investors

Jefferies lifts Hikma target as CMO deal underpins growth story

Jefferies has raised its price target on Hikma Pharmaceuticals PLC (LSE:HIK, OTC:HKMPF) to 2,025p from 1,870p, pointing to the expanding contract manufacturing business as the source of the upgrade. T

22 days ago

EarningsProactive Investors

Hikma jumps 10% as brokers point to profit beat and undemanding rating

Hikma Pharmaceuticals PLC (LSE:HIK, OTC:HKMPF) shares rose 10% to 1,721p after first-half results came in ahead of expectations on profits, with both Peel Hunt and Stifel keeping buy ratings. The scal

last month

AnalystProactive Investors

Hikma recovery story still has further to run after recent rally, says Panmure

Hikma Pharmaceuticals PLC (LSE:HIK, OTC:HKMPF) has already rebounded 30% from its lows but Panmure Liberum believes the generic drugmaker still offers upside if it can rebuild investor confidence foll

2 months ago

AnalystProactive Investors

Citi starts Hikma at 'buy' with strategy reset offering compelling entry point

Citi has initiated coverage of Hikma Pharmaceuticals PLC (LSE:HIK, OTC:HKMPF) with a 'buy' rating and a £17 price target, arguing the generic drugmaker's current valuation offers a compelling entry po

2 months ago